Gender gaps discovered in prescription drug use

Women's health expert calls for further research on women from the "beginning of the drug discovery process.

By SOCIETY FOR WOMEN'S HEALTH RESEARCH (SWHR)
April 7, 2012 01:01
1 minute read.
Gender differences

Gender differences 390. (photo credit: Thinkstock/Imagebank)

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user uxperience almost completely free of ads
  • Access to our Premium Section and our monthly magazine to learn Hebrew, Ivrit
  • Content from the award-winning Jerusalem Repor
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

Women use more prescription drugs than men; yet they are not prescribed proper amounts. In a new study presented at Women's Health 2012: The 20th Annual Congress by Medco Health Solutions, Inc. and the Society for Women's Health Research (SWHR) women are prescribed more drugs than men, have poorer adherence rates to using the drugs than men, and, perhaps most surprisingly, lag behind men in receiving the appropriate drugs for their documented diseases.

Historically, clinical trials have included predominantly men, but medications affect men and women differently. Because sex differences in prescription drug absorption, metabolism and dosage have not been properly researched, women may be left to suffer the consequences.

Be the first to know - Join our Facebook page.


“To adequately bridge the gender gap in medication management, we need to emphasize more research on women from the very beginning of the drug discovery process,” said Phyllis Greenberger, MSW, President and CEO of SWHR. "Research studies need to include women in all trials to determine why women’s adherence to and experience with medication trails behind men’s.”

According to the new study, which included almost 30 million Medco prescription and insurance claims records, gender differences were found in overall prescription drug use, adherence patterns and disease management. For cardiovascular disease (CVD) and diabetes, women showed poorer outcomes than men in 25 out of 25 clinical measures. Usage patterns showed that 68 percent of women in the study took at least one medication over the one year study period compared to 59 percent of men. Women also took an average of five drugs, compared to less than four (3.7) drugs for men. Most importantly, only 59% of women with documented CVD were prescribed appropriate guidance-based treatment.

This landmark study shows that gender-specific dosing is desperately needed in modern medicine. SWHR has long advocated for sex-specific dosing research and guidance on all drugs to prevent harmful reactions in women and to improve their overall health.

This article was first published at www.newswise.com.

Related Content

Lab
August 31, 2014
Weizmann scientists bring nature back to artificially selected lab mice

By JUDY SIEGEL-ITZKOVICH